Allergan Competitors and Similar CompaniesClear all
Allergan's competitors and similar companies include Alcon, Genentech, Amgen, Bausch + Lomb and Teva Pharmaceuticals.
 Allergan Allergan is a healthcare company focused on developing, manufacturing, and commercializing branded pharmaceutical, device, biologic, surgical, and regenerative medicine products. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. |  Bausch + Lomb Bausch + Lomb is a company that develops, manufactures, and markets eye health products. | |||
Founding Date | Founding Date 1948 | Founding Date 1945 | Founding Date 1976 | Founding Date 1980 | Founding Date 1853 | Founding Date 1901 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Dublin, IE HQ Buenos Aires, AR Roseville, AU Machelen, BE Guarulhos, BR Las Condes, CL Bogotá, CO see more | Locations Geneva, CH HQ Macquarie Park, AU Wien, AT Mechelen, BE Mississauga, CA Beijing, CN Praha, CZ see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Vaughan, CA HQ Buenos Aires, AR Vienna, AT Minsk, BY Aalst, BE Porto Alegre, BR São Paulo, BR see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more |
Employees | Employees 10,5471% decrease | Employees 25,000 | Employees 18,077 | Employees 25,200 | Employees 13,500 | Employees 37,000 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) 7.3 b | Valuation ($) 20.8 b |
Financial | ||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $10.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $5.1b (FY, 2025) | Revenue (est.) $17.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.4b (FY, 2025) | Cost of goods N/A | Cost of goods $12b (FY, 2025) | Cost of goods N/A | Cost of goods $8.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $7.2b (FY, 2025) | Gross profit N/A | Gross profit $24.7b (FY, 2025) | Gross profit N/A | Gross profit $8.9b (FY, 2025) |
Net income | Net income N/A | Net income $980m (FY, 2025) | Net income N/A | Net income $7.7b (FY, 2025) | Net income ($352m) (FY, 2025) | Net income $1.4b (FY, 2025) |
Operating ⚠ | ||||||
Countries | Countries 100 (Q1, 2020) | Countries 60 (Sep, 2022) | Countries N/A | Countries 100 (FY, 2020) | Countries N/A | Countries N/A |
Countries (Customers) | Countries (Customers) N/A | Countries (Customers) 140 (Sep, 2022) | Countries (Customers) N/A | Countries (Customers) N/A | Countries (Customers) 100 (FY, 2022) | Countries (Customers) N/A |
Facilities | Facilities 21 (FY, 2019) | Facilities N/A | Facilities N/A | Facilities 180 (FY, 2020) | Facilities N/A | Facilities 90 (FY, 2019) |
Facilities Leased | Facilities Leased 11 (FY, 2019) | Facilities Leased N/A | Facilities Leased N/A | Facilities Leased N/A | Facilities Leased 3 (FY, 2022) | Facilities Leased N/A |
Facilities Owned | Facilities Owned 10 (FY, 2019) | Facilities Owned N/A | Facilities Owned N/A | Facilities Owned N/A | Facilities Owned 11 (FY, 2022) | Facilities Owned N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 28 (Jul, 2025) | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 19 (Jul, 2025) | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 41 (Jul, 2025) | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products N/A | Phase III Trials Products N/A |
For sources of this data, please see the company profile
View Company Profiles
Alcon
HQ
Geneva, CH
Employees
25,000
Alcon is a company that manufactures surgical and vision care products.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View companyAmgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View companyBausch + Lomb
HQ
Vaughan, CA
Employees
13,500
Bausch + Lomb is a company that develops, manufactures, and markets eye health products.
View company